Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2019 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2019 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide

  • Authors:
    • Wenbo Tang
    • Oujing Chen
    • Fengxiang Yao
    • Lining Cui
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Ningbo First Hospital, Ningbo, Zhejiang 315000, P.R. China
    Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4781-4790
    |
    Published online on: October 4, 2019
       https://doi.org/10.3892/mmr.2019.10727
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oxidative stress and dysregulation of antioxidant systems are associated with various complications in pregnancy. Endometriosis is a common gynecologic disease that affects women of reproductive age. Recent studies have indicated that oxidative stress may be involved in the pathophysiology of endometriosis. It has been reported that microRNAs can regulate the cellular response to oxidative stress, and mounting evidence indicates that fatty acid binding protein 4 (FABP4) plays an essential role in the regulation of systemic redox capacity. In the present study, we demonstrated that miR‑455 is a putative FABP4‑targeting miRNA. A luciferase activity assay revealed that miR‑455 can successfully bind to the 3'‑UTR of FABP4. Overexpression of miR‑455 led to the downregulation of FABP4 at both the mRNA and protein levels in a human endometrial stromal cell line. Then, the roles of miR‑455 and FABP4 in oxidative stress induced by hydrogen peroxide (H2O2) in human endometrial stromal cells were examined. We found that ectopic expression of miR‑455 protected cells from damage caused by H2O2. Further investigation found that forced expression of miR‑455 reduced the level of reactive oxygen species (ROS) and malondialdehyde (MDA), while the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH‑Px) were promoted. Silencing of FABP4 also generated cytoprotective effects against H2O2 in human endometrial stromal cells. Moreover, overexpression FABP4 abrogated the miR‑455‑mediated antioxidative stress effects in cells. Taken together, we propose that miR‑455 protects human endometrial stromal cells from oxidative stress at least partly via regulation of FABP4.

Introduction

Endometriosis is a disorder characterized by implantation and growth of endometrial tissue outside the uterine cavity. It has been estimated that approximately 10–15% of women of reproductive age are affected by endometriosis (1). To date, the etiology of endometriosis has yet to be elucidated; many theories have been proposed, but none of them have been substantiated (2–4). Recently, substantial evidence indicates that oxidative stress, which is defined as an imbalance between reactive oxygen species (ROS) and antioxidants, may be involved in the pathophysiology of endometriosis by triggering a general inflammatory response in the peritoneal cavity (5). Consequently, ROS are likely to be associated with different pregnancy-related disorders, such as spontaneous abortions, fetal growth restriction and preeclampsia. Therefore, targeting oxidative imbalance may be applicable as an effective therapeutic strategy against endometriosis.

MicroRNAs (miRNAs) are a group of small non-coding RNAs that regulate the expression of genes at the post-transcriptional level via inhibition of protein translation and decay of mRNAs (6). It is well documented that miRNAs are involved in various biological processes including the response to oxidative stress. For instance, a recent study showed that miR-182-5p inhibits oxidative stress via targeting Toll-like receptor 4 (TLR4) in macrophages (7). Forced expression of miR-210 was found to lead to the reduction of BNIP3 and protected rat myocardial cells from oxidative stress induced by H2O2 (8). miR-29b was found to regulate oxidative stress via targeting SIRT1 in ovarian cancer cells (9). miR-455 has been found to be involved in a variety of cancers, and it was shown that miR-455 could protect osteoblasts from oxidative stress via activation of the Nrf2 signaling pathway (10,11). However, whether miR-455 can alleviate oxidative stress in endometrial stromal cells remains unknown.

Fatty acid binding protein 4 (FABP4), also known as adipocyte FABP (aP2), is a small 15-kDa lipid chaperone that participates in various biological processes such as glucose and lipid homeostasis, inflammation and intracellular fatty acid trafficking (12). A recent study has shown that FABP4−/− macrophages exhibit diminished ROS production (13). In contrast, it was also found that FABP4 plays a cytoprotective role against oxidative and ER stress in adipocytes and that the knockdown of FABP4 causes an increase in cellular ROS levels (14). These findings indicate that FABP4 plays an essential role in the regulation of oxidative stress, and thus, further investigation is warranted in terms of its role in endometriosis.

In the present study, we identified miR-455 as a putative FABP4-targeting miRNA. Forced expression of miR-455 protected endometrial stromal cells from cytotoxicity induced by H2O2. Moreover, silencing of FABP4 generated protective effects similar to those of miR-455, which were abrogated by the ectopic expression of FABP4 in endometrial stromal cells.

Materials and methods

Cell culture and transfection

Immortalized human endometrial stromal cells (HESCs) were purchased from Applied Biological Materials Ltd.. Cells were cultured in a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM) (Gibco™; Thermo Fisher Scientific, Inc.) and Ham's F-12 medium (Gibco™; Thermo Fisher Scientific, Inc.) supplemented with 10% fetal calf serum (FCS) (HyClone; GE Healthcare), 100 U/ml penicillin and streptomycin (HyClone; GE Healthcare). Cells were cultured in a humidified atmosphere with 5% CO2 at 37°C. miR-455 mimics (miR-455), negative control mimics (miR-NC), siRNA against FABP4 (si-FABP4), negative control siRNA (si-NC) and pcDNA3.1-FABP4 (pcFABP4) were purchased from GenePharm. Transfection was performed using Lipofectamine 2000 (Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Unless indicated, the dose of H2O2 used in this study was 20 µM.

Quantitative real-time PCR (qPCR)

Total RNA was extracted from cells using TRIzol reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Briefly, 1 µg of total RNA was used to synthesize cDNA using a TIANScript II cDNA First Chain Synthesis kit (Tiangen Biotech Co., Ltd). Then, qPCR was performed with a miScript SYBR-Green PCR kit (Qiagen, Inc.) on an ABI 7500 system (PE Applied Biosystems™; Thermo Fisher Scientific, Inc.). GAPDH and U6 were used as internal controls. The thermocycling conditions were as follows: 95°C for 1 min, then 40 cycles of 95°C for 15 sec, 55°C for 30 sec and 70°C for 30 sec. The expression levels in tissues and cells were calculated using the 2−ΔΔCq method (15).

Dual-luciferase reporter assay

Two oligonucleotide pairs including FABP4 3′UTR sequences of both the mutant and wild-type sequences were synthesized by Genepharm. After annealing, the oligonucleotides were inserted into the pmirGLO vector (Fig. S1) (Promega, Madison, WI, USA). For luciferase assays, the cells were co-transfected with the corresponding vectors and miR-455a mimics using Lipofectamine 2000 (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. Then, 24 h after transfection, the firefly and Renilla luciferase activities were detected consecutively using a Dual-Luciferase Kit (Promega Corp.). The relative luciferase activity was normalized to that of Renilla luciferase.

Cell viability assay

A CCK-8 assay was performed to measure cell viability after treatment. Briefly, cells (5,000 cells/well) were seeded in a 96-well plate. After treatment, 10 µl of Cell Counting Kit-8 solution (CCK-8; cat. no. c0038, Beyotime Institute of Biotechnology) was added, and the optical density (OD) value of each well was measured at a wavelength of 595 nm using an ELISA microplate reader. Wells without cells served as blanks. The experiments were performed in triplicate and were repeated at least three times.

Apoptosis assay

For apoptosis detection by flow cytometry, the cells were stained with propidium iodide (PI) and Annexin V-FITC (cat. no. v13242; Invitrogen; Thermo Fisher Scientific, Inc.); the fluorescence was then determined by a BD FACSVia™ flow cytometry system (BD Biosciences).

Caspase-3/7 activity assay

The activity of caspase-3/7 was measured using a Caspase-Glo 3/7 Assay kit (cat. no. g8090, Promega) according to the manufacturer's protocol. Briefly, 100 µl of caspase-3/7 reagent was added to each well followed by incubation for 1 h at room temperature. Luminescence was measured as the absorbance at 405 nm. Caspase-3/7 activity was indicated as a percentage of the untreated control. Three independent experiments were performed.

Western blot analysis

After treatment, cells were collected and lysed in RIPA buffer (Beyotime Institute of Biotechnology). Equal amounts of protein extracts (20 µg) were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore). The membrane was blocked with 5% skim milk for 1 h at room temperature. Then, the membrane was incubated with the primary antibody overnight at 4°C. The following primary antibodies were used: FABP4 (cat. no. ab66682; Abcam), actin (cat. no. ab179467; Abcam), and caspase-3 (cat. no. 9662; Cell Signaling Technology). The primary antibodies were diluted at the ratio of 1:1,000 in TBST. Following three washes in TBST for 15 min each, the membranes were incubated with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (cat. no. 7074; Cell Signaling Technology) for 1 h at room temperature. The secondary antibody was diluted at the ratio of 1:10,000 in TBST. The results were visualized using the Super Signal Chemiluminescent Substrate (Pierce; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Protein bands were quantified by densitometric analysis using Quantity One software v4.6.6 (Bio-Rad Laboratories).

Determination of ROS, LDH, CAT, GSH-Px, MDA, and SOD activity

For the assessment of reactive oxygen species (ROS), DCF-DA (Thermo Scientific) was used as an ROS probe, as previously described (16). After different treatments, the cells were incubated with 5 µM DCF-DA for 30 min at 37°C. The stained cells were then analyzed by flow cytometry (FACS Caliber, BD Biosciences). Lactate dehydrogenase (LDH) activity was measured using an LDH ELISA kit (cat. no. MAK066, Sigma-Aldrich; Merck KGaA) according to the manufacturer's instructions. The activities of catalase (CAT), glutathione peroxidase (GSH-Px), malondialdehyde (MDA) and superoxide dismutase (SOD) were determined using commercially available colorimetric assay kits (cat. nos. ab83464, ab239727, ab118970, ab211096, respectively; Abcam) according to the manufacturer's protocols.

Statistical analysis

Data are expressed as the mean ± standard deviation (SD) and were analyzed using SPSS 18.0 (SPSS, Inc.). Statistical comparisons between different groups were measured using Student's t-test or a one-way analysis of variance (ANOVA) with post-hoc Tukey's test. P<0.05 was considered to indicate a statistically significant result.

Results

Hydrogen peroxide induces apoptosis and decreases the expression of miR-455 in human endometrial stromal cells

First, HESCs were treated with various doses of H2O2 for 24 h after which the apoptosis rates were measured. As shown in Fig. 1A, flow cytometric analysis revealed that treatment with H2O2 significantly induced apoptosis of HESCs in a dose-dependent manner. Western blot analysis also demonstrated that H2O2 treatment led to a decrease in pro-caspase-3 and an increase in cleaved caspase-3 in a dose-dependent manner in HESCs (Fig. 1B). Moreover, a caspase-3/7 activity assay further confirmed that treatment with H2O2 significantly increased the activation of caspase-3/7 in a dose-dependent manner in HESCs (Fig. 1C). Then, miR-455 levels were examined in H2O2-treated HESCs, and the results showed that miR-455 levels were significantly reduced in HESCs in a dose-dependent manner following H2O2 treatment. Taken together, these data suggest that miR-455 is likely negatively correlated with apoptosis induced by H2O2 in HESCs.

Figure 1.

H2O2 induces apoptosis and affects the expression of miR-455 in HESCs. (A) Flow cytometry analysis of the apoptosis rates in HESCs exposed to various doses of H2O2 for 24 h. (B) HESCs were treated with various concentrations of H2O2 for 24 h, and then, cellular lysates were collected and subjected to western blot analysis with the caspase-3 antibody. The histograms (right) show the densitometric analysis of the caspase-3 and cleaved caspase-3 western blot results. (C) HESCs were treated with various concentrations of H2O2, after which total cellular lysates were collected and subjected to a caspase-3/7 activity assay. (D) HESCs were treated with various concentrations of H2O2 for 24 h, and then, the levels of miR-455 were measured by qPCR. All data are shown as the mean ± SD of three independent experiments. *P<0.05, **P<0.01 and ***P<0.001. HESCs, human endometrial stromal cells; H2O2, hydrogen peroxide.

Overexpression of miR-455 protects HESCs from H2O2-induced apoptosis

Next, we explored whether miR-455 plays a role in H2O2-induced apoptosis of HESCs. A CCK-8 assay showed that the H2O2-induced reduction in cell viability was significantly reversed by overexpression of miR-455 mimics in HESCs (Fig. 2A). Flow cytometric analysis also indicated that upregulation of miR-455 significantly reduced the apoptosis induced by H2O2 in HESCs (Fig. 2B and Fig. S2). Western blot analysis found that cleavage of caspase-3 induced by H2O2 was diminished by overexpression of miR-455 in HESCs (Fig. 2C). Furthermore, the caspase-3/7 activity assay also revealed that activation of caspase-3/7 induced by H2O2 was repressed by upregulation of miR-455 (Fig. 2D). These results indicate that miR-455 plays a protective role in H2O2-induced apoptosis of HESCs.

Figure 2.

miR-455 inhibits H2O2-induced apoptosis of HESCs. (A) HESCs were treated as indicated for 24 h, and then a CCK-8 assay was performed to detect cell viability. (B) The apoptosis rate of HESCs following the different treatments. (C) HESCs were treated as indicated; subsequently, total cellular lysates were subjected to western blot analysis with the caspase-3 antibody. The histograms shows the densitometric analysis of the caspase-3 (right panel) and cleaved caspase-3 (bottom panel) western blot results. (D) HESCs were treated as indicated. Then, the relative caspase-3/7 activities were determined. All data are shown as the mean ± SD of three independent experiments. *P<0.05; **P<0.01 ***P<0.001. HESCs, human endometrial stromal cells; H2O2, hydrogen peroxide.

miR-455 alleviates the oxidative stress induced by H2O2 in HESCs

We then investigated the effects of miR-455 on oxidative stress induced by H2O2 in HESCs. First, we examined the effect of miR-455 on the intracellular ROS levels induced by H2O2. As shown in Fig. 3A, exposure to H2O2 significantly increased the ROS levels, which were significantly reduced by overexpression of miR-455. MDA is a degradation product of membrane lipid oxidation that can serve as an indicator of oxidative damage (17). To further investigate the antioxidant function of miR-455, the levels of MDA were measured after treatment. As indicated in Fig. 3B, H2O2 treatment led to a significant upregulation of intracellular MDA levels, while overexpression of miR-455 significantly diminished this effect. Furthermore, the activities of endogenous antioxidative enzymes such as SOD, CAT and GSH-Px were also determined. As shown in Fig. 3C-E, H2O2 significantly decreased the SOD, CAT and GSH-Px activities, which were partly reversed by upregulation of miR-455. Taken together, these findings confirmed that miR-455 alleviates oxidative stress in HESCs.

Figure 3.

miR-455 alleviates oxidative stress in HESCs. (A) HESCs were treated as indicated, and then intracellular ROS levels were measured by flow cytometry. (B) HESCs were treated as indicated, after which the MDA activity was assessed. (C) HESCs were treated as indicated, after which the SOD activity was assessed. (D) HESCs were treated as indicated, after which CAT activity was assessed. (E) HESCs were treated as indicated, after which assessment of GSH-Px activity was determined. All data are shown as the mean ± SD of three independent experiments. **P<0.01 and ***P<0.001. HESCs, human endometrial stromal cells; ROS, reactive oxygen species; MDA, malondialdehyde; SOD, superoxide dismutase; CAT, catalase; GSH-Px, glutathione peroxidase.

FABP4 is negatively regulated by miR-455

To identify potential targets of miR-455, the bioinformatic tools TargetScan (www.targetscan.org) and StarBase V2.0 (starbase.sysu.edu.cn) were used. It was shown that miR-455 putatively targets the 3′-UTR of FABP4 mRNA (Fig. 4A). Furthermore, we performed a luciferase reporter assay to further confirm whether miR-455 can directly target the 3′-UTR region of FABP4. Both the FABP4 wild-type (WT) 3′UTR containing the miR-455 binding site and a mutated FABP4 3′-UTR sequence were cloned into luciferase reporter vectors, which were co-transfected with miR-NC or a miR-455 mimic. qPCR analysis revealed that transfection of cells with miR-455 mimics successfully increased the endogenous level of miR-455 compared with the negative control (Fig. 4B). As indicated in Fig. 2C, overexpression of miR-455 significantly (P<0.01) decreased the activity of luciferase encoded by a gene containing FABP4 3′-UTR WT, while it did not affect the activity of luciferase encoded by a gene containing FABP4 3′UTR Mut. Further investigation revealed that miR-455 overexpression significantly decreased the mRNA and protein levels of FABP4 in HESCs (Fig. 4D and E). Collectively, these data indicate that FABP4 is a direct target of miR-455 in HESCs.

Figure 4.

FABP4 is a direct target of miR-455 in HESCs. (A) The predicted miR-455 binding site within the FABP 3′-UTR and a mutated version generated by site-directed mutagenesis. The mutant nucleotides of the FABP4 3′-UTR are labeled in red. (B) HESCs were transfected with miR-455 mimics or miR-NC. Twenty-four hours after transfection, miR-455 expression was measured by qPCR. (C) A luciferase assay was performed using HESCs that were co-transfected with miR-NC or miR-455 and a luciferase reporter containing the full length of FABP4 3′-UTR wild-type (WT) or a mutant type (mut). Luciferase activities were measured 24 h after transfection. (D) qPCR showed that the mRNA levels of FABP4 were decreased in HESCs after transfection with miR-455. (E) Western blot analysis of FABP4 in HESCs after transfection with miR-455. All data are shown as the mean ± SD of three independent experiments. **P<0.01 and ***P<0.001. FABP4, fatty acid binding protein 4; HESCs, human endometrial stromal cells.

Silencing of FABP4 is a phenocopy of the effect of miR-455

Next, to investigate the role of FABP4 in response to oxidative stress in HESCs, we used siRNA to specifically knock down the expression of FABP4. Twenty-four hours after transfection, the expression of FABP4 was measured by qPCR and western blot analysis. The results showed that transfection of cells with si-FABP4 successfully repressed the expression of FABP4 (Fig. 5A and B). CCK-8 assays showed that siFABP4 protects HESCs from the H2O2-induced decrease in cell viability (Fig. 5C). Flow cytometric analysis of apoptosis showed that H2O2-induced apoptosis was reversed by siFABP4 (Fig. 5D and Fig. S3). Furthermore, western blot analysis and caspase-3/7 activity assay revealed that the H2O2-induced activation of caspase-3 was diminished by siFABP4 (Fig. 5E and F).

Figure 5.

Silencing of FABP4 protects HESCs from apoptosis induced by H2O2 in HESCs. (A) HESCs were transfected with si-NC or si-FABP4 for 24 h, and then, the mRNA levels of FABP4 were measured by qPCR. (B) HESCs were transfected with si-NC or si-FABP4 for 24 h. The protein levels of FABP4 were then assessed by western blot analysis. (C) HESCs were treated as indicated for 24 h, which was followed by a CCK-8 assay to detect cell viability. (D) The apoptosis rate of HESCs following the different treatments. (E) HESCs were treated as indicated, after which the total cellular lysates were subjected to western blot analysis with the caspase-3 antibody. The histogram shows the densitometric analysis of the caspase-3 (right panel) and cleaved caspase-3 (bottem panel) western blot results. (F) HESCs were treated as indicated, after which the relative caspase-3/7 activities were assayed. All data are shown as the mean ± SD of three independent experiments. *P<0.05, **P<0.01 and ***P<0.001. FABP4, fatty acid binding protein 4; H2O2, hydrogen peroxide; HESCs, human endometrial stromal cells.

Upregulation of FABP4 diminishes the protective effects of miR-455 against H2O2

To further investigate the role of FABP4, HESCs were transfected with miR-455 mimics and the FABP4 overexpression vector alone or in combination. qPCR and western blot analysis revealed that the FABP4 vector significantly upregulated the level of FABP4 (Fig. 6A and B). A CCK-8 assay showed that overexpression of FABP4 significantly diminished the protective effects of miR-455 against H2O2 (Fig. 6C). In addition, flow cytometric analysis showed that upregulation of FABP4 abrogated the protective role of miR-455 against apoptosis induced by H2O2 (Fig. 6D and Fig S4). Moreover, western blot analysis and the caspase-3/7 activity assay showed that overexpression of FABP4 significantly abrogated the inhibitory effect of miR-455 on the activation of caspase-3 induced by H2O2 (Fig. 6E and F).

Figure 6.

Ectopic expression of FABP4 abolishes the protective effects of miR-455 against H2O2. (A) qPCT analysis of FABP4 mRNA levels after ectopic expression of FABP4 for 24 h. (B) Western blot analysis of FABP4 protein levels after ectopic expression of FABP4 for 24 h. (C) HESCs were treated as indicated for 24 h, and then, a CCK-8 assay was performed to detect cell viability. (D) The apoptosis rate of HESCs following the different treatments. (E) HESCs were treated as indicated, and then, total cellular lysates were subjected to western blot analysis with the caspase-3 antibody. The histogram shows the densitometric analysis of the caspase-3 and cleaved caspase-3 western blotresults. (F) HESCs were treated as indicated, after which the relative caspase-3/7 activities were assayed. All data are shown as the mean ± SD of three independent experiments. **P<0.01 and ***P<0.001. FABP4, fatty acid binding protein 4; H2O2, hydrogen peroxide; HESCs, human endometrial stromal cells.

Discussion

In the present study, we examined the effects of miR-455 on oxidative stress in human endometrial stromal cells (HESCs). It was found that miR-455 was decreased by H2O2 in a dose-dependent manner. In addition, ectopic expression of miR-455 alleviated cellular damage induced by H2O2 in HESCs. It was also demonstrated that miR-455 inhibited H2O2-induced intracellular reactive oxygen species (ROS) production and the malondialdehyde (MDA) level; this effect was accompanied by significantly increased activities of catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). Moreover, fatty acid binding protein 4 (FABP4) was identified as a target of miR-455. Since oxidative stress is implicated in the pathophysiology of endometriosis as it causes a general inflammatory response in the peritoneal cavity, our findings suggest that miR-455 may be applied as part of a more optimized therapy for endometriosis.

H2O2 has been extensively applied as an inducer of oxidative stress in various in vitro models. H2O2 readily enters the cytoplasm and thereafter produces a more toxic hydroxyl radical that interacts with macromolecules such as lipids, proteins and DNA, which leads to cellular damage (18). To evaluate H2O2-related cellular damage, a CCK-8 assay and flow cytometry, which are widely used to evaluate the effect of pharmacological agents on cell proliferation and apoptosis, were performed. The results of our study revealed that H2O2 decreased the viability and increased the apoptosis of HESCs in a dose-dependent manner. Another significant finding was that H2O2 also decreased the expression of miR-455 in a dose-dependent manner. Although no previous study to date has reported the protective effect of miR-455 against oxidative stress in HESCs, Xu et al demonstrated that miR-455 targets cullin 3 to activate Nrf2 signaling and protects human osteoblasts from cellular damage induced by H2O2 (11). Moreover, in a recent study, Zhang et al showed that miR-455 protects osteoblasts from oxidative stress through activation of Nrf2/ARE signaling (10). Our results further confirmed that miR-455 overexpression largely relieved oxidative stress in HESCs and revealed that H2O2 inhibited HESC growth, at least in part, via downregulation of miR-455.

Many studies have shown that H2O2 exerts oxidative stress via inducing apoptosis in vitro (19, 20). Oxidative stress activates caspases, which are a group of cysteine proteases that act as death effector molecules, and after activation, they cleave various substrates in the cytoplasm or nucleus (21,22). Two pathways lead to apoptosis, namely, the extrinsic and intrinsic pathways (22). The extrinsic pathway is initiated by caspase-8, while the intrinsic pathway is initiated by caspase-9 (22). The activation of caspase-8 and/or caspase-9 leads to the activation of caspase-3, which is the executioner caspase that can cleave different substrates and finally induce apoptosis (21,22). Our study, which is in agreement with a previous study, indicated that a relatively low concentration of H2O2 induced apoptosis, which was accompanied by activation of caspase-3 in HESCs (23). In the present study, ectopic expression of miR-455 obviously restrained the H2O2-induced apoptosis in HESCs. Mounting evidence has confirmed that H2O2-induced accumulation of ROS, which can lead to cell damage and apoptosis, is implicated in the pathophysiology of endometriosis (24). The results of our study indicated that 20 µM of H2O2 markedly increased the level of ROS, which was repressed by overexpression of miR-455. Moreover, overexpression of miR-455 markedly alleviated oxidative stress, as evidenced by the decreased MDA level and increased SOD, CAT and GSH-Px activities. Therefore, we concluded that miR-455 alleviated oxidative stress and thereby provides protection against H2O2 in HESCs.

FABP4, which has been identified as a direct downstream target of miR-455, belongs to the FABP family. It has been reported that FABP1, another member of the FABP family, functions as an antioxidant protein since it neutralizes free radicals through its methionine and cysteine amino acids (25). However, the role of FABP4 in the regulation of oxidative stress is still controversial. Many studies have shown that inhibition of FABP4 could suppress inflammation and oxidative stress in various models (26,27). In contrast, another study showed that the knockdown of FABP4 upregulates the intracellular ROS levels in adipocytes (14). The discrepancy may be due to different cell models, and therefore, further investigation is needed. In the present study, it was found that the antioxidant effects of miR-455 could be mimicked by downregulation of FABP4 and abrogated by overexpression of FABP4. Therefore, our study implies that targeting of FABP4 may be an effective strategy against oxidative stress in the treatment of endometriosis.

Taken together, our study provides new insight into the mechanisms by which miR-455 alleviates oxidative stress in HESCs. Additionally, we identified FABP4 as a direct target of miR-455. Hence, these results provide strong evidence that miR-455 may be an effective target for the treatment of endometriosis.

Supplementary Material

Supporting Data

Acknowledgements

Not applicable.

Funding

This study was supported by a grant from the Natural Foundation of Ningbo Science and Technology Bureau, China (grant no. 2018A610323).

Availability of data and materials

The datasets used during the present study are available from the corresponding author upon reasonable request.

Authors' contributions

WT and OC performed experiments; FY performed the statistical analysis of the data; LC designed the study and drafted the manuscript. All authors read and approved the manuscript and agree to be accountable for all aspects of the research in ensuring that the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors state that they have no competing interests.

References

1 

Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A and Saridogan E; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group, : ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 20:2698–2704. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Sampson JA: Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 3:93–110.43. 1927.PubMed/NCBI

3 

Sourial S, Tempest N and Hapangama DK: Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2014:1795152014. View Article : Google Scholar : PubMed/NCBI

4 

Vinatier D, Orazi G, Cosson M and Dufour P: Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol. 96:21–34. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V and Creatsas G: Pathogenesis of endometriosis: The role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 12:194–202. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Qin SB, Peng DY, Lu JM and Ke ZP: miR-182-5p inhibited oxidative stress and apoptosis triggered by oxidized low-density lipoprotein via targeting toll-like receptor 4. J Cell Physiol. 233:6630–6637. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Diao H, Liu B, Shi Y, Song C, Guo Z, Liu N, Song X, Lu Y, Lin X and Li Z: MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3. Biosci Biotechnol Biochem. 81:1712–1720. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Hou M, Zuo X, Li C, Zhang Y and Teng Y: Mir-29b regulates oxidative stress by targeting SIRT1 in ovarian cancer cells. Cell Physiol Biochem. 43:1767–1776. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Zhang S, Wu W, Jiao G, Li C and Liu H: miR-455-3p activates Nrf2/ARE signaling via HDAC2 and protects osteoblasts from oxidative stress. Int J Biol Macromol. 107:2094–2101. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Xu D, Zhu H, Wang C, Zhu X, Liu G, Chen C and Cui Z: microRNA-455 targets cullin 3 to activate Nrf2 signaling and protect human osteoblasts from hydrogen peroxide. Oncotarget. 8:59225–59234. 2017.PubMed/NCBI

12 

Furuhashi M and Hotamisligil GS: Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 7:489–503. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Steen KA, Xu H and Bernlohr DA: FABP4/aP2 regulates macrophage redox signaling and inflammasome activation via control of UCP2. Mol Cell Biol. 37(pii): e00282–16. 2017.PubMed/NCBI

14 

Kajimoto K, Minami Y and Harashima H: Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes. FEBS Open Bio. 4:602–610. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Xu Y, Wang W, Jin K, Zhu Q, Lin H, Xie M and Wang D: Perillyl alcohol protects human renal tubular epithelial cells from hypoxia/reoxygenation injury via inhibition of ROS, endoplasmic reticulum stress and activation of PI3K/Akt/eNOS pathway. Biomed Pharmacother. 95:662–669. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Tsukahara H: Biomarkers for oxidative stress: Clinical application in pediatric medicine. Curr Med Chem. 14:339–351. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Halliwell B, Clement MV, Ramalingam J and Long LH: Hydrogen peroxide. Ubiquitous in cell culture and in vivo? IUBMB Life. 50:251–257. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Singh M, Sharma H and Singh N: Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion. 7:367–373. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Clement MV, Ponton A and Pervaiz S: Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett. 440:13–18. 1998. View Article : Google Scholar : PubMed/NCBI

21 

Degterev A, Boyce M and Yuan J: A decade of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI

22 

Thornberry NA: Caspases: A decade of death research. Cell Death Differ. 6:1023–1027. 1999. View Article : Google Scholar : PubMed/NCBI

23 

Zal F, Khademi F, Taheri R and Mostafavi-Pour Z: Antioxidant ameliorating effects against H2O2-induced cytotoxicity in primary endometrial cells. Toxicol Mech Methods. 28:122–129. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, Greco P and Nappi L: Oxidative stress and endometriosis: A systematic review of the literature. Oxid Med Cell Longev. 2017:72652382017. View Article : Google Scholar : PubMed/NCBI

25 

Yan J, Gong Y, She YM, Wang G, Roberts MS and Burczynski FJ: Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. J Lipid Res. 50:2445–2454. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Gong Y, Yu Z, Gao Y, Deng L, Wang M, Chen Y, Li J and Cheng B: FABP4 inhibitors suppress inflammation and oxidative stress in murine and cell models of acute lung injury. Biochem Biophys Res Commun. 496:1115–1121. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Rahman N, Jeon M and Kim YS: Methyl gallate, a potent antioxidant inhibits mouse and human adipocyte differentiation and oxidative stress in adipocytes through impairment of mitotic clonal expansion. Biofactors. 42:716–726. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tang W, Chen O, Yao F and Cui L: miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide. Mol Med Rep 20: 4781-4790, 2019.
APA
Tang, W., Chen, O., Yao, F., & Cui, L. (2019). miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide. Molecular Medicine Reports, 20, 4781-4790. https://doi.org/10.3892/mmr.2019.10727
MLA
Tang, W., Chen, O., Yao, F., Cui, L."miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide". Molecular Medicine Reports 20.6 (2019): 4781-4790.
Chicago
Tang, W., Chen, O., Yao, F., Cui, L."miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide". Molecular Medicine Reports 20, no. 6 (2019): 4781-4790. https://doi.org/10.3892/mmr.2019.10727
Copy and paste a formatted citation
x
Spandidos Publications style
Tang W, Chen O, Yao F and Cui L: miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide. Mol Med Rep 20: 4781-4790, 2019.
APA
Tang, W., Chen, O., Yao, F., & Cui, L. (2019). miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide. Molecular Medicine Reports, 20, 4781-4790. https://doi.org/10.3892/mmr.2019.10727
MLA
Tang, W., Chen, O., Yao, F., Cui, L."miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide". Molecular Medicine Reports 20.6 (2019): 4781-4790.
Chicago
Tang, W., Chen, O., Yao, F., Cui, L."miR‑455 targets FABP4 to protect human endometrial stromal cells from cytotoxicity induced by hydrogen peroxide". Molecular Medicine Reports 20, no. 6 (2019): 4781-4790. https://doi.org/10.3892/mmr.2019.10727
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team